Pharmacokinetic consideractions in the therapeutic application of cyclosporine in renal transplantationKAHAN, B. D.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2143-2146, issn 0041-1345Conference Paper

Immunosuppressive therapy, 1987KAHAN, B. D.Texas Heart Institute journal. 1987, Vol 14, Num 4, pp 351-358, issn 0730-2347Article

Current Approaches to the Use of Sirolimus In Renal TransplantationKAHAN, B. D.Transplantation proceedings. 2009, Vol 41, Num 8, pp 3011-3015, issn 0041-1345, 5 p.Conference Paper

The evolution of therapeutic drug monitoring of cyclosporineKAHAN, B. D.Transplantation proceedings. 2001, Vol 33, Num 7-8, pp 3086-3088, issn 0041-1345Article

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre studyKAHAN, B. D.Lancet (British edition). 2000, Vol 356, Num 9225, pp 194-202, issn 0140-6736Article

Immunosuppressive agents acting upon lymphokine synthesis and signal transductionKAHAN, B. D.Clinical transplantation. 1993, Vol 7, Num 1, pp 113-125, issn 0902-0063, 2Article

Toward a rational design of clinical trials of immunosuppressive agents in transplantationKAHAN, B. D.Immunological reviews. 1993, Vol 136, pp 29-49, issn 0105-2896Article

Immunosuppressive therapy with cyclosporine for cardiac transplantationKAHAN, B. D.Circulation (New York, N.Y.). 1987, Vol 75, Num 1, pp 40-56, issn 0009-7322Article

The emerging matrix of immunosuppressive agentsKAHAN, B. D.Transplantation proceedings. 2003, Vol 35, Num 6, pp 2365-2368, issn 0041-1345, 4 p.Conference Paper

The three fates of immunosuppression in the next millenium : selectivity, synergy, and specificityKAHAN, B. D.Transplant international. 1996, Vol 9, Num 6, pp 527-534, issn 0934-0874Article

Pharmacology of Synergism Among Immunosuppressive Drugs for TransplantationKAHAN, B. D.Clinical pharmacology and therapeutics. 2011, Vol 90, Num 2, pp 303-309, issn 0009-9236, 7 p.Article

The potential role of rapamycin in pediatric transplantation as observed from adult studiesKAHAN, B. D.Pediatric transplantation. 1999, Vol 3, Num 3, pp 175-180, issn 1397-3142Article

Considerations concerning generic formulations of immunosuppressive drugs : Guidelines for the use of cyclosporine formulationsKAHAN, B. D.Transplantation proceedings. 1999, Vol 31, Num 3, pp 1635-1641, issn 0041-1345Conference Paper

Synergism, how assessed and how achievedKAHAN, B. D.Clinical transplantation. 1991, Vol 5, Num 6, pp 534-539, issn 0902-0063, 2Article

Mankind's three millenia : one Maverick's three decades in the struggle against biochemical individualityKAHAN, B. D.Transplantation. 1991, Vol 51, Num 1, pp 1-21, issn 0041-1337, 21 p.Conference Paper

I: Nature of the agent and its immunologic actions: proceedings/2nd international congress on cyclosporine, November 4-7, 1987, Washington DCKAHAN, B. D.Transplantation proceedings. 1988, Vol 20, Num 2, issn 0041-1345, 734 p., suppl. 2Conference Proceedings

A pilot study of steroid withdrawal from kidney transplant recipients on sirolimus-cyclosporine a combination therapyMAHALATI, K; KAHAN, B. D.Transplantation proceedings. 2001, Vol 33, Num 7-8, pp 3232-3233, issn 0041-1345Article

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantationLINDHOLM, A; KAHAN, B. D.Clinical pharmacology and therapeutics. 1993, Vol 54, Num 2, pp 205-218, issn 0009-9236Article

Area under the curve monitoring of cyclosporine therapy : the early posttransplant periodGREVEL, J; KAHAN, B. D.Therapeutic drug monitoring. 1991, Vol 13, Num 2, pp 89-95, issn 0163-4356, 7 p.Article

Proceedings/International conference on the pharmacology of cyclosporine, Hardangervidda, Norway, July 31-August 3, 1986KAHAN, B. D.Transplantation proceedings. 1986, Vol 18, Num 6, issn 0041-1345, 273 p., suppl. 5Conference Proceedings

Impact of the timing of antigen administration on synergistic immunosuppression with cyclosporineYOSHIMURA, N; KAHAN, B. D.Transplantation. 1985, Vol 40, Num 1, pp 109-110, issn 0041-1337Article

Prolongation of allograft survival by repeated cycles of donor antigen and cyclosporine in rat kidney transplantationYASUMURA, T; KAHAN, B. D.Transplantation. 1984, Vol 38, Num 4, pp 418-423, issn 0041-1337Article

Better Actual 10-Year Renal Transplant Outcomes of 80% Reduced Cyclosporine Exposure With Sirolimus Base Therapy Compared With Full Cyclosporine Exposure Without or With Concomittant Sirolimus TreatmentPLISZCZYNSKI, J; KAHAN, B. D.Transplantation proceedings. 2011, Vol 43, Num 10, pp 3657-3668, issn 0041-1345, 12 p.Article

Page / 10